Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
393.6 USD | -0.15% | -1.04% | -3.31% |
07:01pm | UBS Adjusts Vertex Pharmaceuticals Price Target to $466 From $498, Maintains Buy Rating | MT |
02:36pm | Guggenheim Adjusts Vertex Pharmaceuticals' Price Target to $450 From $445 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.31% | 102B | |
+3.33% | 96.09B | |
-1.02% | 22.05B | |
-18.34% | 20.81B | |
-6.87% | 19.06B | |
-40.70% | 16.05B | |
-26.01% | 14.01B | |
+1.76% | 13.38B | |
+22.92% | 11.01B | |
-18.73% | 9.12B |
- Stock Market
- Equities
- VRTX Stock
- News Vertex Pharmaceuticals Incorporated
- RBC Capital Adjusts Price Target on Vertex Pharmaceuticals to $267 From $274, Keeps Sector Perform Rating